Vasculitis
- Recommendations and Guidelines
- Criteria and Outcome Measures
- Disease Scores and Online Calculators
- Imaging Tools
- Organisations and further links
Recommendations and Guidelines
EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update
(Ann Rheum Dis.2023 Mar 16;ard-2022-223764.)
https://ard.bmj.com/content/early/2023/03/16/ard-2022-223764
EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis.
(Ann Rheum Dis. 2016;75:1583-94.)
http://ard.bmj.com/content/75/9/1583.full?sid=55d485e0-a8c0-4f43-aa46-0ffe9fa81269.
CanVasc Recommendations for the Management of Antineutrophil Cytoplasm Antibody-associated Vasculitides.
(J Rheumatol. 2016;43:97-120.)
http://www.jrheum.org/content/43/1/97.long
BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis.
(Rheumatology (Oxford). 2014;53:2306-9.)
http://rheumatology.oxfordjournals.org/content/53/12/2306.long
Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management.
(Eur J Intern Med. 2015;26:545-53.)
http://www.sciencedirect.com/science/article/pii/S0953620515001442
Management of giant cell arteritis: Recommendations of the French Study Group for Large Vessel Vasculitis (GEFA).
(Rev Med Interne. 2016;37:154-65.)
http://www.sciencedirect.com/science/article/pii/S0248866315011303
Management of Polymyalgia Rheumatica: 2015 Recommendations for the Management of Polymyalgia Rheumatica A European League Against Rheumatism/American College of Rheumatology Collaborative Initiative
(Arthritis Rheum. 2015;67:2569-80.)
https://onlinelibrary.wiley.com/doi/abs/10.1002/art.39333
BSR and BHPR guidelines for the management of giant cell arteritis.
(Rheumatology (Oxford). 2010;49:1594-7.)
http://rheumatology.oxfordjournals.org/content/49/8/1594.long
EULAR recommendations for the management of large vessel vasculitis.
(Ann Rheum Dis. 2009;68:318-23.)
http://ard.bmj.com/content/68/3/318.long
EULAR recommendations for the management of Behçet disease.
(Ann Rheum Dis. 2008;67:1656-62.)
http://ard.bmj.com/content/67/12/1656.long
Criteria and Outcome Measures
2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.
(Arthritis Rheum. 2013;65:1-11.)
http://onlinelibrary.wiley.com/doi/10.1002/art.37715/full
Validation of the classification criteria for cryoglobulinaemic vasculitis
(Rheumatology (Oxford). 2014;53:2209-13.)
https://academic.oup.com/rheumatology/article/53/12/2209/1804597
International Study Group Criteria for Diagnosis of Behcet’s Disease
(Lancet. 1990;335:1078-80.)
http://www.thelancet.com/journals/lancet/article/PII0140-6736(90)92643-V/fulltext
International Criteria for Behçet's Disease
(J Eur Acad Dermatol Venereol. 2014;28:338-47.)
http://onlinelibrary.wiley.com/doi/10.1111/jdv.12107/full
Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies
(Ann Rheum Dis 2007;66:222-7)
http://www.ncbi.nlm.nih.gov/pubmed?term=16901958
Anti-neutrophil cytoplasm antibodies (ANCA): Recent methodological advances—Lead to new consensus recommendations for ANCA detection
(J Immunol Methods. 2018;456:1-6)
http://www.ncbi.nlm.nih.gov/pubmed?term=16901958
ACR/EULAR diagnosis and classification criteria in vasculitis study (DCVAS)
https://research.ndorms.ox.ac.uk/public/dcvas/
ACR 1990 classification criteria for GCA
(Arthritis Rheum. 1990;33:1122-8.)
http://www.rheumatology.org/Portals/0/Files/Giant%20Cell%20(Temporal)%20Arteritis%20-%201990_Completed%20Article.pdf
The OMERACT core set of outcome measures for use in clinical trials of ANCA-associated vasculitis
(J Rheumatol 2011;38:1480-6)
http://www.jrheum.org/content/38/7/1480.long
Disease Scores and Online Calculators
Birmingham Vasculitis Activity Score (BVAS v.3)
(Ann Rheum Dis 2009;68:1827-32)
http://ard.bmj.com/content/68/12/1827.full
BVAS online calculator
http://golem.ndorms.ox.ac.uk/calculators/bvas.html
Birmingham Vasculitis Activity Score – GPA
(Arthritis Rheum. 2001;44:912-20.)
http://onlinelibrary.wiley.com/doi/10.1002/1529-0131(200104)44:4%3C912::AID-ANR148%3E3.0.CO;2-5/full
Five-Factor Score
http://www.canvasc.ca/pdf/2009FFSrevised.pdf
Indian Takayasu Clinical Activity Score
(Rheumatology (Oxford). 2013;52:1795-801.)
http://rheumatology.oxfordjournals.org/content/52/10/1795.long
Vasculitis Activity Index
(Arthritis Rheum 1999;42:2365–71)
http://onlinelibrary.wiley.com/doi/10.1002/1529-0131(199911)42:11%3C2365::AID-ANR15%3E3.0.CO;2-M/pdf
IgG4-Related Disease Responder Index
(Int J Rheumatol. 2012;2012:259408.)
https://www.hindawi.com/journals/ijr/2012/259408/
BVAS and VDI training
https://bvasvdi.org/
The Vasculitis Damage Index
(Arthritis Rheum 1997;40:371-80)
http://onlinelibrary.wiley.com/doi/10.1002/art.1780400222/pdf
The Combined Damage Assessment Index (CDA)
(Ann Rheum Dis. 2011;70:80-5)
http://www.ncbi.nlm.nih.gov/pubmed/20736392.1
Imaging Tools
Official site of the SONOgraphy on VASculitis (SONOVAS) study group with giant cell arteritis images database.
https://sites.google.com/site/sonovasculitis/home
Organisations and further links
Vasculitis Clinical Research Consortium
http://rarediseasesnetwork.epi.usf.edu/vcrc/index.htm